Guardant Health
(NASDAQ) GH
Guardant Health Financials at a Glance
Market Cap
$12.55B
Revenue (TTM)
$1.08B
Net Income (TTM)
$433.19M
EPS (TTM)
$-3.40
P/E Ratio
-28.14
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$95.70
Volume
3,186,826.002
Open
$96.57
Price
$95.70
Volume
3,186,826.002
Open
$96.57
Previous Close
$95.70
Daily Range
$89.07 - $98.50
52-Week Range
$36.36 - $120.74
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$95.70
Volume
3,186,826.002
Open
$96.57
Previous Close
$95.70
Daily Range
$89.07 - $98.50
52-Week Range
$36.36 - $120.74
GH News
GH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Guardant Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
2,506
CEO
Helmy Eltoukhy, PhD; AmirAli H. Talasaz, PhD
Website
www.guardanthealth.comHeadquarters
Palo Alto, CA 94063, US
GH Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
-41%
Net Income Margin
-40%
Return on Equity
0%
Return on Capital
-28%
Return on Assets
-23%
Earnings Yield
-3.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.55B
Shares Outstanding
131.17M
Volume
3.19M
Avg. Volume
2.00M
Financials (TTM)
Gross Profit
$633.01M
Operating Income
$436.30M
EBITDA
$373.91M
Operating Cash Flow
$184.76M
Capital Expenditure
$48.31M
Free Cash Flow
$233.07M
Cash & ST Invst.
$1.20B
Total Debt
$1.68B
Guardant Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$301.67M
+48.3%
Gross Profit
$196.75M
+52.8%
Gross Margin
65.22%
N/A
Market Cap
$12.55B
N/A
Market Cap/Employee
$6.28M
N/A
Employees
1,999
N/A
Net Income
$112.08M
-17.8%
EBITDA
$100.91M
-20.4%
Quarterly Fundamentals
Net Cash
$573.77M
+5.6%
Accounts Receivable
$137.40M
+19.0%
Inventory
$83.85M
+8.5%
Long Term Debt
$1.68B
+31.3%
Short Term Debt
$0.00
-100.0%
Return on Assets
-22.62%
N/A
Return on Invested Capital
-27.57%
N/A
Free Cash Flow
$71.20M
-6.0%
Operating Cash Flow
$65.62M
-4.7%